Integer (NYSE:ITGR) Sees Large Volume Increase - Here's What Happened

Integer Holdings Co. (NYSE:ITGR - Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 307,111 shares were traded during mid-day trading, a decline of 2% from the previous session's volume of 314,283 shares.The stock last traded at $118.10 and had previously closed at $117.18.

Analyst Ratings Changes

Several equities research analysts have issued reports on ITGR shares. Truist Financial increased their price target on Integer from $147.00 to $163.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Benchmark raised their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, February 21st. KeyCorp boosted their price objective on shares of Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Finally, Wells Fargo & Company restated an "overweight" rating and issued a $160.00 price target on shares of Integer in a report on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $148.56.

Integer Trading Down 0.3 %

The business has a 50-day moving average of $130.47 and a 200-day moving average of $131.97. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 34.85, a P/E/G ratio of 1.72 and a beta of 1.24.

Remove Ads

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million during the quarter, compared to the consensus estimate of $446.28 million. Research analysts anticipate that Integer Holdings Co. will post 6.01 EPS for the current year.

Institutional Investors Weigh In On Integer

A number of institutional investors and hedge funds have recently modified their holdings of ITGR. Blue Trust Inc. raised its stake in Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock valued at $220,000 after buying an additional 71 shares during the period. Arizona State Retirement System lifted its stake in shares of Integer by 0.9% during the 4th quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock worth $1,290,000 after buying an additional 84 shares during the last quarter. HighTower Advisors LLC lifted its position in Integer by 0.8% during the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider's stock worth $1,579,000 after acquiring an additional 90 shares during the last quarter. HighPoint Advisor Group LLC lifted its position in Integer by 6.4% during the fourth quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 101 shares during the last quarter. Finally, Norden Group LLC boosted its holdings in shares of Integer by 7.0% during the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock worth $221,000 after acquiring an additional 109 shares during the period. 99.29% of the stock is owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.